Journals / Hacettepe Journal of Biology and Chemistry / 2017 / Cilt: 45 - Sayı: 3

Effect of Aspartame on Acetylcholinesterase Activity in Some of Rat Tissues

Aspartamın Sıçanların Beyin, Karaciğer, Böbrek ve Akciğer Dokularında Asetilkolinesteraz Aktivitesi Üzerine Etkisi

Pages
321–327
Publication Date
2017-09-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Consequently, it was observed that aspartame caused increases in the activities of AChE in the liver and kidney during the first hours after treatment but lost its effect at later times.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, the changes in acetylcholinesterase AChE activity in the liver, lungs, kidney and brain tissues were investigated in the rats administered aspartame intraperitoneally.
📊
Key Findings & Data:Aspartame, a widely used artificial sweetener, was given to the rats at doses of 50, 100 and 200 mg/kg.
💡
Conclusion & Impact:Consequently, it was observed that aspartame caused increases in the activities of AChE in the liver and kidney during the first hours after treatment but lost its effect at later times.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Asetilkolinesteraz · aspartam · enzim aktivitesi

Abstract

In this study, the changes in acetylcholinesterase AChE activity in the liver, lungs, kidney and brain tissues were investigated in the rats administered aspartame intraperitoneally. Aspartame, a widely used artificial sweetener, was given to the rats at doses of 50, 100 and 200 mg/kg. Changes in enzyme activity were recorded at 12 and 24 h following the injection. The activities of AChE at 12 h for all doses were significantly higher in the liver and kidney but not in those of lung and brain. However, the activities in the liver and kidney at 24 h after treatment for 200 mg/kg were similar to that of control. Consequently, it was observed that aspartame caused increases in the activities of AChE in the liver and kidney during the first hours after treatment but lost its effect at later times.

Özet

B u çalışmada, sıçanlara intraperional verilen aspartamın, karaciğer, akciğer, böbrek ve beyin dokularında asetilkolinesteraz AChE aktivitesindeki değişiklikler araştırıldı. Yapay tatlandırıcı olarak yaygın bir şekilde kullanılan aspartam, erkek Wistar sıçanlara n= 36 50, 100 ve 200 mg/kg olarak verildi. Enjeksiyonu takiben 12 ve 24 saat sonra enzim aktivitesindeki değişiklikler kaydedildi. 12 saatteki bütün dozlarda AChE aktiviteleri karaciğer ve böbrekte önemli bir şekilde daha yüksekti. Fakat akciğer ve beyinde aynı yüksek değerler gözlenmedi. Buna rağmen, 200 mg/kg uygulamasından 24 saat sonra karaciğer ve böbrekteki aktiviteler kontrolünkiyle benzerdi. Sonuç olarak, sıçanın farklı dokularında aspartamın AChE enzim aktivitelerinde bazı değişiklere neden olduğu bulundu. AChE enzim aktivitelerindeki değişikliklerin nedenleri bu çalışmada tartışıldı

🔖

Cite This Article

POLAT, F., DERE, E., ARI, F., TURAÇLAR, N., BİNGÖL, G., AZTOPAL, N. (2017). Effect of Aspartame on Acetylcholinesterase Activity in Some of Rat Tissues. Hacettepe Journal of Biology and Chemistry, Cilt: 45 - Sayı: 3, 321–327. https://ajindex.com/articles/255873

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. I. Saldamlı, Gıda Katkı Maddeleri ve İngrediyenler, HÜ Gıda Müh. Bl., Ankara, (1985) 120-121. American Dietetic Association. Position of the American Dietetic Association, Use of nutritive and nonnutritive sweeteners, J. Am. Diet. Assoc., 10 (2004) 255-275.
  2. Ş.G. Öz, Aspartam: Güvenilirliği üzerine yapılan tartışma, Ankara Üni. Tıp Fak. Mecmuası., 56 (2003) 113-120.
  3. L. Fix, J.L. Allen, Summary of the symposium establishing the safety of fat and macronutrient substitutes presented at the 33rd Annual Meeting of the Society of Toxicology, San Diego, California, March 13-17, (1994), Regul. Toxicol. Pharmacol., 27 (1998) 200-203.
  4. H.H. Butchko, W.W. Stargel, Aspartame: Scientific evaluation in the postmarketing period, Regul. Toxicol. Pharmacol., 34 (2001) 221-233.
  5. G.D. Castro, M.H. Costantini, A.M. Delgado de layno, A. Castro, Rat liver microsomal and nuclear activation of methanol to hydroxyl methyl free radicals, Toxicol. Lett., 129 (2002) 227- 236. J.N. Parthasarathy, S.K. Ramasundaram, M. Sundaramahalingam, S.D. Pathinasamy, Methanol induced oxidative stress in rat lymphoid organs, J. Occup. Health., 48 (2006) 20-27.
  6. A. Vences-Mejia, N. Labra-Ruiz, N. Hernandez- Martinez, V. Dorado-Gonzales, J. Gomez-Garduno, I. Perez-Lopez, R. Nosti-Palacios, R. Camocho-Carranza, J.J. Espinosa-Aguirre, The effect of aspartame on rat brain xenobiotic-metabolizing enzymes, Human Exp. Toxicol., 25 (2006) 453-459.
  7. M.M. Iman, Effect of aspartame on some oxidative stres parameters in liver and kidney of rats, Afr. J. Pharm. Pharmacol., 5 (2011) 678-682.
  8. A. Iyyaswamy, S. Rathinasamy, Effect of chronic exposure to aspartame on oxidative stress in the brain of albino rats, J. Biosci., 37 (2012) 679–688.
  9. K.C. Arbind, D.R. Sheela, L. Sundareswaran, Role of antioxidant enzymes in oxidative stress and immune response evaluation of aspartame in blood cells of Wistar albino rats, Int. Food Res. J., 21 (2014) 2263- 2272. C. Puicâ, C. Crâciun, M. Borsa, M. Rusu, I. Roman, M. Cristescu, Protective effects of a biactive antioxidant complex against aspartame exposure during gestation biochemical morphological and ultra structurel studies on new-born rat brain, Life Scien., 18 (2008) 195-208.
  10. L. Stanley, Review of data on the food additive aspartame, Supporting Publications, European Food Safety Authority, 399 (2013) 45-50.
  11. A. Sarıtaş, Z. Çakır, Ş. Aslan, Organofosfat ve karbamat zehirlenmeleri, The Eurasian J. Med., 39 (2007) 55-59.
  12. S.M. Moreira, L. Guilhermino, The use of mytilus galloprivinc